Concepedia

Seiji Doi

SD

Statistics

Publications

14

Citations

850

H-Index

12

Active since

2001

Affiliations

Nagasaki University(Current)

Sasebo City General Hospital

Kawasaki Medical School

Nagasaki Municipal Hospital

Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital

Seiji Doi is an author at Nagasaki University specializing in medicine, oncology, and cancer pharmacology.

Publications per year

2001–2013

14

Publications

14

Gefitinib, an EGFR tyrosine kinase inhibitor, directly inhibits the function of P-glycoprotein in multidrug resistant cancer cells

Takeshi Kitazaki, Mikio Oka, Yoichi Nakamura et al. · Lung Cancer · 2005 · 179 citations

, , +13

Gefitinib (“Iressa”, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses Breast Cancer Resistance Protein/ABCG2–Mediated Drug Resistance

Yoichi Nakamura, Mikio Oka, Hiroshi Soda et al. · Cancer Research · 2005 · 177 citations · Full text

, , +15

Reversal of breast cancer resistance protein (BCRP/ABCG2)‐mediated drug resistance by novobiocin, a coumermycin antibiotic

Ken Shiozawa, Mikio Oka, Hiroshi Soda et al. · International Journal of Cancer · 2003 · 121 citations

, , +16

Expression and functional analyses of breast cancer resistance protein in lung cancer.

Shigeru Kawabata, Mikio Oka, Hiroshi Soda et al. · PubMed · 2003 · 94 citations

, , +17

The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells

Seiji Doi, Hiroshi Soda, Mikio Oka et al. · Molecular Cancer Therapeutics · 2004 · 69 citations · Full text

, , +17

1–5 of 14